摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-amino-5-(3-bromophenyl)-2,4-dioxo-1,3,4,5-tetrahydro-2H-pyrano[2,3-d]pyrimidine-6-carbonitrile

中文名称
——
中文别名
——
英文名称
7-amino-5-(3-bromophenyl)-2,4-dioxo-1,3,4,5-tetrahydro-2H-pyrano[2,3-d]pyrimidine-6-carbonitrile
英文别名
7-amino-5-(3-bromophenyl)-2,4-dioxo-1,5-dihydropyrano[2,3-d]pyrimidine-6-carbonitrile
7-amino-5-(3-bromophenyl)-2,4-dioxo-1,3,4,5-tetrahydro-2H-pyrano[2,3-d]pyrimidine-6-carbonitrile化学式
CAS
——
化学式
C14H9BrN4O3
mdl
——
分子量
361.154
InChiKey
AXQIOAGDEBGCTE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    22
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    117
  • 氢给体数:
    3
  • 氢受体数:
    5

反应信息

  • 作为产物:
    描述:
    巴比妥酸间溴苯甲醛丙二腈 在 1,1'-(butane-1,4-diyl)bis(1H-imidazol-3-ium) perchlorate 作用下, 以 为溶剂, 反应 0.33h, 以95%的产率得到7-amino-5-(3-bromophenyl)-2,4-dioxo-1,3,4,5-tetrahydro-2H-pyrano[2,3-d]pyrimidine-6-carbonitrile
    参考文献:
    名称:
    引入了两种新的基于咪唑的双阳离子布朗斯台德酸性离子液体,并比较了它们在巴比妥酸衍生物合成中的催化活性†
    摘要:
    在本文中,报道了制备双咪唑硫酸氢盐和双咪唑高氯酸盐作为两种新的基于咪唑的双阳离子布朗斯台德酸性离子液体。通过FT-IR,质谱,NMR光谱和pH滴定法进行表征后,研究了这些试剂在促进5-亚芳基巴比妥酸和吡喃并[2,3- d ]嘧啶酮衍生物的合成中的适用性。这些方法具有一些优点,例如易于制备催化剂,简单的后处理步骤,短的反应时间,优异的产率以及在反应的所有步骤中使用非有机溶剂以及催化剂的良好可重复使用性。
    DOI:
    10.1039/c8nj01179f
点击查看最新优质反应信息

文献信息

  • Three-component synthesis of 4<i>H</i>-pyran scaffolds accelerated by a gabapentin-based natural deep eutectic solvent
    作者:Meysam Alipour Khoshdel、Farhad Shirini、Mohaddeseh Safarpoor Nikoo Langarudi、Mehdi Zabihzadeh、Mohammad Biglari
    DOI:10.1039/d0nj05342b
    日期:——
    catalyst for the synthesis of 4H-pyran scaffolds such as tetrahydrobenzo[b]pyran and pyrano[2,3-d]pyrimidinone(thione) derivatives. The use of inexpensive and bio-compatible reagents for the synthesis of the catalyst, a simple and green procedure for the preparation of the catalyst and products, short reaction times, high yields of the products, and applicability to large-scale synthesis are the prominent
    在最近的有机合成中,对环境无害的合成方法的发展引起了越来越多的关注。作为这一概念的一部分,我们的小组使用加巴喷丁氯化胆碱合成了一种新型的天然深共熔溶剂(NADES)。在通过FTIR,1 H和13 C NMR以及质谱进行表征后,所制备的NADES被用作合成4 H-喃骨架如四氢苯并[ b ]喃和喃并[2,3- d ]的有效催化剂。]嘧啶酮(酮)衍生物。廉价的和生物相容性试剂用于催化剂的合成,用于催化剂和产物的制备的简单且绿色的过程,短的反应时间,产物的高产率以及适用于大规模合成是突出的问题。该协议的功能。而且,该催化剂可以容易地回收并循环多达五次,而不会显着损失其催化活性。
  • SCMNPs@Urea/Py-CuCl<sub>2</sub>: a recyclable catalyst for the synthesis of pyrano[2,3-<i>d</i>]pyrimidinone and pyrano[2,3-<i>d</i>] pyrimidine-2,4,7-trione derivatives
    作者:Jun Zhang、Hongqing Song、Ruirui Cui、Chaoyong Deng、Qahtan A. Yousif
    DOI:10.1080/00958972.2020.1737681
    日期:2020.2.16
    Abstract An efficient, simple, and mild strategy for the one-pot multicomponent synthesis of pyrano[2,3-d]pyrimidinone and pyrano[2,3-d]pyrimidine-2,4,7-trione derivatives is described using SCMNPs@Urea/Py-CuCl2 nanoparticles as a reusable heterogeneous magnetic nanocatalyst. The catalyst was characterized using Fourier transform infrared spectroscopy (FTIR), thermogravimetric analysis (TGA), vibrating
    摘要描述了使用 SCMNPs@ 一锅多组分合成喃并[2,3-d]嘧啶酮和并[2,3-d]嘧啶-2,4,7-三酮衍生物的高效、简单和温和的策略。尿素/Py-CuCl2 纳米颗粒作为可重复使用的异质磁性纳米催化剂。使用傅里叶变换红外光谱 (FTIR)、热重分析 (TGA)、振动样品磁强计 (VSM)、能量色散 X 射线光谱 (EDX)、X 射线衍射 (XRD) 和扫描电子显微镜 (SEM) 对催化剂进行表征。 )。SCMNPs@Urea/Py-CuCl2 可以很容易地通过使用永磁场的磁滗析从反应溶液中收集,并在六次运行中重复使用,催化活性不会显着降低。图形概要
  • Nano-Zn[2-boromophenylsalicylaldiminemethylpyranopyrazole]Cl<sub>2</sub>as a novel nanostructured Schiff base complex and catalyst for the synthesis of pyrano[2,3-<i>d</i>]pyrimidinedione derivatives
    作者:A.R. Moosavi-Zare、H. Goudarziafshar、Z. Jalilian
    DOI:10.1002/aoc.4584
    日期:2019.1
    several techniques. Nano‐[Zn‐2BSMP]Cl2 was used as an effective catalyst for the preparation of some pyrano[2,3‐d]pyrimidinedione derivatives by the multicomponent reaction of malononitrile, aryl aldehydes and barbituric acid derivatives. The novelty and efficiency of nano‐[Zn‐2BSMP]Cl2 as a catalyst, in comparison with some other reported catalysts, for this synthetic transformation are the main features
    制备了一种新型的纳米结构的席夫碱复合物纳米Zn [2-苯基苯基水杨醛亚胺基甲基喃并吡唑] Cl 2(nano [Zn-2BSMP] Cl 2),并使用多种技术对其进行了表征。纳米[Zn-2BSMP] Cl 2被用作通过丙二腈,芳基醛和巴比妥酸生物的多组分反应制备某些喃并[2,3- d ]嘧啶二酮衍生物的有效催化剂。与其他报道的催化剂相比,纳米[Zn-2BSMP] Cl 2作为催化剂的新颖性和效率是这项工作的主要特征。
  • Jin, Tong-Shou; Liu, Li-Bin; Zhao, Ying, Journal of Chemical Research, 2005, # 3, p. 162 - 163
    作者:Jin, Tong-Shou、Liu, Li-Bin、Zhao, Ying、Li, Tong-Shuang
    DOI:——
    日期:——
查看更多

同类化合物

叔-丁基2-(甲磺酰)-5,7-二氢螺[吡喃并[4,3-D]嘧啶并-8,3-吡咯烷]-1-甲酸基酯 乙基7'-氨基-6-氟-2,2',4'-三羰基-1,1',2,2',3',4'-六氢螺[吲哚-3,5'-吡喃并[2,3-d]嘧啶]-6'-羧酸酯 7H-吡喃并[2,3-d]嘧啶-7-酮 7H-吡喃并[2,3-d]嘧啶 7,8-二氢-5H-吡喃并[4,3-D]嘧啶-2-胺 5H-吡喃并[4,3-d]嘧啶 5H-吡喃并[2,3-d]嘧啶 2H-吡喃并[2,3-d]嘧啶-6-甲腈,7-氨基-1,3,4,5-四氢-5-(4-甲氧苯基)-2,4-二羰基- 2,4-二氯-7,8-二氢-5H-吡喃[4,3-d]嘧啶 1H-吡喃并[3,4-d]嘧啶 1H-吡喃并[3,2-d]嘧啶 (5S,7R,8S)-2-methylsulfanyl-5,8-dihydro-7-allyloxymethyl-5-methoxy-pyrano[3,4-d]-pyrimidin-8-ol 5-ethyl-2-[(Z)-1-thiophen-3-ylpentylideneamino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione 5-ethyl-2-[[1-(3-methylbutanoyl)piperidin-4-ylidene]amino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione 5-butyl-2-[(E)-1-(4-cyclohexylpiperazin-1-yl)butylideneamino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione 2,3,3a,9-tetrahydro-5-iodo-2,3,3-trimethylimidazo[5,1-b][1,3]benzoxazin-1-one 2,4-dimethyl-9-methoxy-4,12b-dihydro-1H,7H-chromeno[4',3'-4,5]pyrano[2,3-d]pyrimidine-1,3(2H)-dione 5-methyl-3-{3-[(R)-2-oxo-3-(3-oxo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazin-6-yl)-oxazolidin-5-yl]-propyl}-1H-quinazoline-2,4-dione 7-amino-2-(benzothiazol-2-ylmethyl)-9-phenylthiazolo[4',5':6,5]pyrano[2,3-d]pyrimidine-8(7H)-one 2-[6-[(2-chlorophenyl)methyl]pyridin-2-yl]-7,8-dihydro-5H-pyrano[4,3-d]pyrimidine 8-amino-2-(methylthio)-5-oxo-6-(pyridin-4-yl)-5,6-dihydro-4H-pyrano[2,3-d][1,3]thiazolo[4,5-b]pyridine-7-carbonitrile 5-(4-chlorophenyl)-1,3,8,8-tetramethyl-7,9-dihydro-5H-chromeno[2,3-d]pyrimidine-2,4,6-trione ethyl 7'-amino-2,4'-dioxo-2'-thioxo-1,1',2,2',3',4'-hexahydrospiroindole-3,5'-pyrano[2,3-d]pyrimidine-6'-carboxylate 8-amino-2-(methylthio)-5-oxo-6-(pyridin-3-yl)-5,6-dihydro-4H-pyrano[2,3-d][1,3]thiazolo[4,5-b]pyridine-7-carbonitrile 7-Amino-4-oxo-5-phenyl-2-thioxo-1,3,4,5-tetrahydro-2H-pyrano[2,3-d]pyrimidine-6-carboxylic acid ethyl ester 3-(1H-benzoimidazol-2-yl)-3-butyl-5-methyl-dihydro-furan-2-one 3-(1H-benzoimidazol-2-yl)-3-(2-diethylamino-ethyl)-5-methyl-dihydro-furan-2-one 1-{4-[(1R,9S)-3-((S)-3-methyl-morpholin-4-yl)-12-oxa-4,6-diaza-tricyclo[7.2.1.0-2,7]dodeca-2(7),3,5-trien-5-yl]-phenyl}-3-oxetan-3-yl-urea (S)-6-(4-(4-(3-ethylmorpholino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl)phenylamino)pyridin-2(1H)-one 3-(1H-benzoimidazol-2-yl)-5-methyl-3-(3-methyl-butyl)-dihydro-furan-2-one 13-(3,4-dimethoxyphenyl)-5,5-dimethyl-2-thioxo-2,5,6,8,9,13-hexahydro-4H-pyrimido[5',4':6,7][1,8]naphthyridino[4,3,2-de]quinazoline-10,12(3a1H,11H)-dione (S)-3-allyl-8-ethyl-4,7-dioxo-2-(phenylcarbamoyl)-4,5,7,8-tetrahydro-3H-pyrano[4,3-d]pyrimidin-8-yl acetate 8-{[(2-bromo-3-methylphenyl)oxy]methyl}-1,3-dimethyl-2,3,4,6-tetrahydro-1H-pyrano[3,2-d]pyrimidine-2,4-dione 9-ethyl-6a-methyl-2-phenyl-8,9-dihydro-oxazolo[2,3-b]pyrimido[4,5-d][1,3]oxazin-5-one (S)-1-cyclobutyl-3-(4-(4-(3-methylmorpholino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl)phenyl)urea (S)-2-(4-(4-(3-ethylmorpholino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl)phenylamino)pyrimidin-4(3H)-one (6aRS,10aRS)-4,6,6a,7,8,9,10,10a-octahydro-2,4,6,6-tetramethyl-1H-<2>benzopyrano<3,4-d>pyrimidine-1,3(2H)-dione 5-ethyl-2-[(E)-1-thiophen-3-ylpentylideneamino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione N3-(methyl 4-deoxy-α-L-threo-hex-4-enopyranosyluronate)-5-fluorouracil 1-{4-[(1S,9R)-3-((S)-3-methyl-morpholin-4-yl)-12-oxa-4,6-diaza-tricyclo[7.2.1.0-2,7]dodeca-2(7),3,5-trien-5-yl]-phenyl}-3-oxetan-3-yl-urea 4,5-dimethyl-12-(4-methoxyphenyl)-2-thioxo-2,4a,7,8,9,10,11,12-octahydrodipyrimido[4,5-b;4',5'-f] [1,8]naphthyridine-9,11-dione 2-[4-[2-hydroxyethyl(methyl)amino]-2-methyl-7-oxopyrimido[5,4-b][1,4]oxazin-8-yl]acetonitrile 5-ethyl-2-[(Z)-1-thiophen-2-ylethylideneamino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione